Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Akermin logo — Pioneering Next-Gen Biofuel Cells and Enzyme Applications fo...

Akermin

Pioneering Next-Gen Biofuel Cells and Enzyme Applications for Diverse Industries

Founded 2003 Grant Total: $25.48M Biotechnology, Health Care +3

General Information

Company Name Akermin
Founded Year 2003
Industries Biotechnology, Health Care, IT +2
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Akermin. To contact Akermin, visit akermin.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Akermin compare?

A PDF of Akermin and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Akermin soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Akermin

Akermin, established in 2004 in St. Louis, Missouri, is "Pioneering Next-Gen Biofuel Cells and Enzyme Applications for Diverse Industries" as per their slogan. The company's main focus is on commercial applications in wireless sensors and military uses, utilizing innovative stabilized enzyme technology created at Saint Louis University. Akermin showcased a prototype biofuel cell by 2008 that operates on methanol fuel and uses stabilized laccase as a replacement for the metal catalyst in traditional cathodes. The development of stabilized enzymes for use in the food processing, biofuels, chemical, and pharmaceutical industries is also underway. The company operates within the Biotechnology, Health Care, IT, Manufacturing, Autonomous, and Sensor Tech industries. Akermin received a $3.00M grant investment on 21 October 2013. The investors for this last investment are currently undisclosed.

Business keywords: Biofuel Cells, Enzyme Applications, Stabilized Enzyme Technology, Methanol Fuel, Laccase, Wireless Sensors, Military Applications, Food Processing, Biofuels Industry, Chemical Industry, Pharmaceutical Industry, Saint Louis University, Innovative Technology, Commercialization, Prototype Development

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $3.00M -
21 Oct 2013
Debt Financing $1.30M -
08 Aug 2013
Venture Round $1.50M 3
St. Louis Arch Angels Prolog Ventures Malaysian Life Sciences Capital Fund
St. Louis Arch Angels, Prolog Ventures +1
19 Feb 2013
Venture Round $4.08M -
05 Jan 2011
Series B $10.00M 5
Chrysalix OnPoint Technologies Prolog Ventures
Chrysalix, OnPoint Technologies +3
26 Jan 2010
Debt Financing $600.00K -
17 Aug 2009
Series A $5.00M 4
Chrysalix OnPoint Technologies St. Louis Arch Angels
Chrysalix, OnPoint Technologies +2
12 Nov 2007
Series A Undisclosed 3
Chrysalix OnPoint Technologies Prolog Ventures
Chrysalix, OnPoint Technologies +1
01 Nov 2005
Seed Round Undisclosed -
01 Mar 2004

Akermin Alternatives & Competitors

View All Alternatives
Akermin vs
MMS
MMS United States

The difference is in the data.

Private Equity
2212 employees
Biotechnology, Health Care
Akermin vs
SimpliSafe
SimpliSafe United States

There's no safe like SimpliSafe.

Debt Financing
1194 employees
Consumer Electronics, Manufacturing
Akermin vs
Innovent Biologics
Innovent Biologics China

To develop and commercialize high-quality biopharmaceuticals that are affordable to ordinary people

Post-IPO Equity
846 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Akermin

Pioneering Next-Gen Biofuel Cells and Enzyme Applications for Diverse Industries
Akermin was founded in 2003.
Akermin operates in Biotechnology, Health Care, IT, Manufacturing and Autonomous and Sensor Tech. Its work centres on Biofuel Cells, Enzyme Applications, Stabilized Enzyme Technology and Methanol Fuel.
Akermin has completed 9 funding rounds, raising a total of $25.48M. The latest funding stage is Grant.
Top alternatives and competitors to Akermin include MMS, SimpliSafe, Innovent Biologics, Koenigsegg Automotive AB, Daylight Solutions. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Akermin and MMS are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Akermin, https://bouncewatch.com/company/akermin, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout